Regional analgesia and cancer outcomes: Our current understanding in 2024
- PMID: 39081922
- PMCID: PMC11285883
- DOI: 10.4103/ija.ija_475_24
Regional analgesia and cancer outcomes: Our current understanding in 2024
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71:209–49. - PubMed
-
- Hiller JG, Perry NJ, Poulogiannis G, Riedel B, Sloan EK. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15:205–18. - PubMed
-
- Xing W, Chen DT, Pan JH, Chen YH, Yan Y, Li Q, et al. lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivo. Anesthesiology. 2017;126:868–81. - PubMed
-
- Cata JP, Ramirez MF, Velasquez JF, Di AI, Popat KU, Gottumukkala V, et al. Lidocaine stimulates the function of natural killer cells in different experimental settings. Anticancer Res. 2017;37:4727–32. - PubMed
Publication types
LinkOut - more resources
Full Text Sources